Clinical Trials Logo

Cancer Pain clinical trials

View clinical trials related to Cancer Pain.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06392399 Not yet recruiting - Perinael Cancer Clinical Trials

Interventions for the Management of Perineal Cancer Pain

Start date: June 2024
Phase: N/A
Study type: Interventional

Pain associated with neoplasms may be of somatic, visceral, or neuropathic origin.Visceral pain or pain that is mediated by the sympathetic fibers in the perineal area associated with malignancy in the pelvis may be effectively treated with neurolysis of impar ganglion.In recent years, radiofrequency lesioning of the ganglion Impar has evolved as a novel non pharmacological technique for the management of patients suffering from intractable perineal pain.

NCT ID: NCT06354049 Not yet recruiting - Cancer Pain Clinical Trials

Reiki Therapy to Improve Key Symptoms in Integrative Oncology Clinic (REIKI)

Start date: April 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to investigate the delivery of Reiki to integrative oncology patients and assess its potential for improving cancer-related symptoms in this population.

NCT ID: NCT06328751 Not yet recruiting - Quality of Life Clinical Trials

Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service

Start date: March 31, 2024
Phase: N/A
Study type: Interventional

Cancer is a disabling, challenging and growing global disease. Although early diagnosis and adequate treatment of oncological disease have been developing rapidly, a large part of the population remains without access to specialized services and routinely evolve to symptoms and sequelae with uncontrolled pain, worse quality of life and suffering. Complementary therapies to control pain and improve the well-being of cancer patients are fundamental tools of integrative oncology medicine. This study proposes to use immersive virtual reality to encourage cancer patients to carry out the regular practice of meditation, as an effective tool in pain management and in the search for a better quality of life, based on a structured intervention that encourages autonomy as important part of your treatment. Two studies will be carried out at the Pain Therapy and Palliative Care Service of the Amazonas State Oncology Control Center Foundation (FCECON). Study 1 will be a cross-sectional study to describe the variables associated with the diagnosis and treatment of patients' pain and Study 2 will be a Randomized Controlled Trial that will analyze the impact of an intervention performed with meditation through immersive virtual reality for pain relief. pain in these patients. It is expected that the regular practice of meditation through immersive virtual reality will promote pain relief and improve the quality of life of cancer pain patients.

NCT ID: NCT06287515 Not yet recruiting - Hypophysectomy Clinical Trials

Hypophysectomy by Stereotactic Radiosurgery for Cancer-Related Pain

Start date: August 31, 2024
Phase: Phase 1
Study type: Interventional

To learn if hypophysectomy (treatment of the pituitary gland) using a type of radiation treatment called stereotactic radiosurgery (SRS) can help to relieve cancer-related pain.

NCT ID: NCT06248216 Not yet recruiting - Cancer Clinical Trials

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

Start date: February 2024
Phase: N/A
Study type: Interventional

We propose an innovative approach to symptom management in cancer patients following cancer treatments, utilizing a Multimodal Integrative Therapy (MIT) delivered via Virtual Reality (VR) program, authorized by the US Food and Drug Administration for in-home use. Our primary goal is to generate pilot data on the effects of MIT-VR program on pain, fatigue, sleep, and anxiety in participants suffering from chronic cancer symptoms following cancer treatments.

NCT ID: NCT06188286 Not yet recruiting - Cancer Pain Clinical Trials

The Effect of Patient-Controlled TEAS vs Sham TEAS for Improve Quality of Life in Patients With Cancer Pain

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This is a randomized controlled clinical pilot study to evaluate the evidence-based basis for transcutaneous acupoint electrical stimulation to improve the quality of life of patients with cancer pain。

NCT ID: NCT06085313 Not yet recruiting - Depressive Symptoms Clinical Trials

Cancer Pain Management Using a Web-based Intervention

CAI
Start date: April 15, 2024
Phase: N/A
Study type: Interventional

Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and coaching/support program for cancer pain management (CAPA) that was culturally tailored to Asian American breast cancer survivors using multiple unique features. However, CAPA rarely considered depressive symptoms accompanying pain in its design or components, and PSs indicated the necessity of further individualization of the intervention components of CAPA due to diversities in the needs of ABD. The purpose of the proposed 2-phase study is to further develop CAPA with additional components for ABD and the individual optimization functionality (CAI) and to test the efficacy of CAI in improving cancer pain experience of ABD. The specific aims are to: a) develop and evaluate CAI through an expert review and a usability test (R61 phase); b) determine whether the intervention group (that uses CAI and usual care) will show significantly greater improvements than the active control group (that uses CAPA and usual care) in primary outcomes (cancer pain management and cancer pain experience including depressive symptoms) from baseline to post 1-month and post 3-months; c) identify theory-based variables (attitudes, self-efficacy, perceived barriers, and social influences) that mediate the intervention effects of CAI on the primary outcomes; and d) determine whether the effects of CAI on the primary outcomes are moderated by selected background, disease, genetic, and situational factors. This study is guided by the Bandura's Theory and the stress and coping framework by Lazarus and Folkman. The R61 phase includes: (a) the intervention development process, (b) a usability test among 15 ABD, 15 family members, and 15 community gatekeepers; and (c) an expert review among 10 experts in oncology. The R33 phase adopts a randomized repeated measures control group design among 300 ABD. Long-term goals are: (a) to extend and test CAI in various healthcare settings with diverse subgroups of ABD, (b) examine the costeffectiveness, sustainability, and scalability of CAI in the settings, and (c) translate CAI into health care for ABD.

NCT ID: NCT06035731 Not yet recruiting - Cancer Pain Clinical Trials

Evaluation of the Medical Service by Socio-aesthetics in Oncology

RCT-SE
Start date: March 2024
Phase: N/A
Study type: Interventional

the 3-year randomized controlled RCT-SE study aims to investigate Socio-aesthetics well being care on quality of life, pain and anxiety. The primary objective is to show that socio-aesthetics well being care improves quality of life during cancer treatment, compared to self care administration of dermo-cosmetics products The secondary objectives are to show that socio-aesthetics well being care significantly reduced anxiety and pain compared to self care administration of dermo-cosmetics products

NCT ID: NCT05744089 Not yet recruiting - Carcinoma Clinical Trials

Home Management of Simple Hydromorphone PCA Pump Mode

Start date: February 2023
Phase: N/A
Study type: Interventional

This prospective observational study will evaluate the efficacy and adverse effects of a "simple hydromorphone PCA pump model", which is a rapid titration followed by a convenient maintenance technique, to treat home cancer patients with severe or critical cancer pain or refractory cancer pain.

NCT ID: NCT05730972 Not yet recruiting - Clinical trials for Non Small Cell Lung Cancer

TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer

Start date: December 15, 2023
Phase: N/A
Study type: Interventional

This multicenter, prospective, randomized controlled research study aims to objectively evaluate the role of transcutaneous electrical acupoint stimulation (TEAS), which combines the theory of acupuncture with transcutaneous electrical nerve stimulation (TENS) therapy, for the treatment of pain in patients with bone metastases from lung cancer.